A proposal to rename and classify aplastic anemia as Myeloaplastic syndrome (MAS) Type I and II

被引：0
|
作者：
Venniyoor, A. [1 ]
机构：
[1] Command Hosp CC, Dept Med & Oncol, Lucknow 226002, Uttar Pradesh, India
来源：
MEDICAL HYPOTHESES | 2010年 / 74卷 / 06期
关键词：
MYELOPROLIFERATIVE NEOPLASMS; CLASSIFICATION;
D O I：
10.1016/j.mehy.2010.01.034
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1085 / 1086
页数：2
相关论文
共 50 条
  • [1] Type I and type II T-cell profiles in aplastic anemia and refractory anemia
    Tsuda, H
    Yamasaki, H
    AMERICAN JOURNAL OF HEMATOLOGY, 2000, 64 (04) : 271 - 274
  • [2] Hematopoietic Stem Cell Regulation by Type I and II Interferons in the Pathogenesis of Acquired Aplastic Anemia
    Smith, Julianne N. P.
    Kanwar, Vikramjit S.
    MacNamara, Katherine C.
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [3] Aplastic crisis as a complication of congenital dyserythropoietic anemia type II
    Heimpel, H.
    Wilts, H.
    Hirschmann, W. D.
    Hofmann, W. K.
    Siciliano, R. D.
    Steinke, B.
    Wechsler, J. G.
    ACTA HAEMATOLOGICA, 2007, 117 (02) : 115 - 118
  • [4] HLA class I and II alleles profile in Indian patients with aplastic anemia
    Mishra, Vikash Chandra
    Chandra, Dinesh
    Bhardwaj, Amit Kr
    Raina, Anoushka
    Dubey, Vijay Kumar
    Sharma, Girish
    Raina, Vimarsh
    GENE REPORTS, 2022, 26
  • [5] The Frequency of HLA Class I and II Alleles in Pakistani Patients with Aplastic Anemia
    Rehman, Sadia
    Saba, Nusrat
    Khalilullah
    Munir, Saeeda
    Ahmed, Parvez
    Mehmood, Tariq
    IMMUNOLOGICAL INVESTIGATIONS, 2009, 38 (08) : 812 - 819
  • [6] A PHASE I/II STUDY OF INTERLEUKIN-3 IN PATIENTS WITH APLASTIC-ANEMIA AND MYELODYSPLASIA
    NIMER, SD
    PAQUETTE, RL
    IRELAND, P
    RESTA, D
    YOUNG, D
    GOLDE, DW
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (09) : 875 - 880
  • [7] Overlap of epitopes recognized by anti-carbonic anhydrase I IgG in patients with malignancy-related aplastic anemia-like syndrome and in patients with aplastic anemia
    Jankovicova, Barbora
    Skultety, Ludovit
    Dubrovcakova, Maria
    Stern, Martin
    Bilkova, Zuzana
    Lakota, Jan
    IMMUNOLOGY LETTERS, 2013, 153 (1-2) : 47 - 49
  • [8] Interferon therapy in congenital dyserythropoietic anemia type I/II
    Marwaha, RK
    Bansal, D
    Trehan, A
    Garewal, G
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2005, 22 (02) : 133 - 138
  • [9] A PHASE I/II TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-6 IN PATIENTS WITH APLASTIC-ANEMIA
    SCHREZENMEIER, H
    MARSH, JCW
    STROMEYER, P
    MULLER, H
    HEIMPEL, H
    GORDONSMITH, EC
    RAGHAVACHAR, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (02) : 283 - 292
  • [10] PHASE-I/II STUDY OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN APLASTIC-ANEMIA AND MYELODYSPLASTIC SYNDROME
    ANTIN, JH
    SMITH, BR
    HOLMES, W
    ROSENTHAL, DS
    BLOOD, 1988, 72 (02) : 705 - 713
12345